Thompson Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Thompson Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.09M	Buy	105,721 +507	+0.5%	+$29.1K	0.7%	59
2026 Q1	$6.38M	Sell	105,214 -281	-0.3%	-$16.4K	0.83%	50
2025 Q4	$5.69M	Buy	105,495 +2,542	+2%	+$122K	0.71%	56
2025 Q3	$4.64M	Buy	102,953 +3,900	+4%	+$182K	0.62%	59
2025 Q2	$4.59M	Sell	99,053 -128	-0.1%	-$6.28K	0.65%	56
2025 Q1	$6.05M	Sell	99,181 -2,786	-3%	-$162K	0.91%	42
2024 Q4	$5.77M	Sell	101,967 -4,229	-4%	-$236K	0.83%	48
2024 Q3	$5.49M	Buy	106,196 +13,746	+15%	+$645K	0.78%	51
2024 Q2	$3.84M	Buy	92,450 +11,973	+15%	+$536K	0.59%	65
2024 Q1	$4.36M	Buy	80,477 +7,737	+11%	+$394K	0.66%	60
2023 Q4	$3.73M	Buy	72,740 +688	+1%	+$36.1K	0.6%	66
2023 Q3	$4.18M	Buy	72,052 +2,085	+3%	+$128K	0.74%	51
2023 Q2	$4.47M	Buy	69,967 +2,679	+4%	+$180K	0.73%	53
2023 Q1	$4.66M	Buy	67,288 +4,365	+7%	+$308K	0.79%	49
2022 Q4	$4.53M	Sell	62,923 -714	-1%	-$53.8K	0.83%	48
2022 Q3	$4.52M	Sell	63,637 -58,436	-48%	-$4.24M	0.88%	43
2022 Q2	$9.4M	Sell	122,073 -26,974	-18%	-$2.05M	1.63%	8
2022 Q1	$10.9M	Sell	149,047 -6,252	-4%	-$420K	1.6%	9
2021 Q4	$9.68M	Buy	155,299 +18,425	+13%	+$1.08M	1.37%	17
2021 Q3	$8.1M	Buy	136,874 +2,915	+2%	+$192K	1.21%	24
2021 Q2	$8.95M	Buy	133,959 +12,535	+10%	+$817K	1.29%	20
2021 Q1	$7.67M	Buy	121,424 +10,628	+10%	+$661K	1.16%	23
2020 Q4	$6.87M	Buy	110,796 +4,097	+4%	+$252K	1.17%	24
2020 Q3	$6.43M	Buy	106,699 +645	+0.6%	+$38.8K	1.21%	21
2020 Q2	$6.24M	Sell	106,054 -4,656	-4%	-$278K	1.21%	26
2020 Q1	$6.17M	Sell	110,710 -2,128	-2%	-$130K	1.37%	15
2019 Q4	$7.24M	Buy	+112,838	New	+$6.46M	1.17%	22

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thompson Investment Management's BMY Position: Q2 2026 in Review

Thompson Investment Management increased its Bristol-Myers Squibb (BMY) stake by 0.48% in Q2 2026, buying an estimated $29.1K and bringing the position to 105,721 shares worth $6.09M. The position accounts for 0.7% of the portfolio, ranked #59.

Thompson Investment Management first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $10.9M in Q1 2022. 800 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Thompson Investment Management held 105,721 shares of Bristol-Myers Squibb worth $6.09M as of Q2 2026.
Thompson Investment Management bought 507 Bristol-Myers Squibb shares in Q2 2026, an estimated $29.1K.
Bristol-Myers Squibb made up 0.7% of Thompson Investment Management's portfolio in Q2 2026, its #59 holding.
Thompson Investment Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
Thompson Investment Management's Bristol-Myers Squibb position peaked at $10.9M in Q1 2022.
800 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.